drugset / Trial / NCT01885104

Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003)

NCT01885104

Phase 2 Completed 65 enrolled Bayer
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the safety and tolerability of oral ingestion of PEG 3350 solution concentrate to oral ingestion of a placebo solution concentrate, in participants with constipation.

Timeline

Start
2013-04
Primary completion
2013-09
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject POLYETHYLENE GLYCOL 3350 Small molecule 17 g Oral
Background Bisacodyl Small molecule 5 mg

Indications